Eton Pharmaceuticals (ETON) Insider Trading & Ownership $14.06 -0.33 (-2.26%) As of 10:46 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eton Pharmaceuticals (NASDAQ:ETON) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.89%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$462.67KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$504.32K Get ETON Insider Trade Alerts Want to know when executives and insiders are buying or selling Eton Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ETON Insider Buying and Selling by Quarter Eton Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/16/2025David KrempaInsiderSell10,223$14.73$150,584.79 6/13/2025David KrempaInsiderSell6,800$14.77$100,436.00 6/12/2025David KrempaInsiderSell16,977$14.92$253,296.84 10/7/2024Opaleye Management Inc.Major ShareholderBuy11,248$7.22$81,210.56 10/4/2024Opaleye Management Inc.Major ShareholderBuy16,852$6.77$114,088.04 9/10/2024Opaleye Management Inc.Major ShareholderBuy57,500$4.65$267,375.00 (Data available from 1/1/2013 forward) ETON Insider Trading Activity - Frequently Asked Questions Who is on Eton Pharmaceuticals' Insider Roster? The list of insiders at Eton Pharmaceuticals includes David Krempa, Opaleye Management Inc., and Sean Brynjelsen. Learn more on insiders at ETON. What percentage of Eton Pharmaceuticals stock is owned by insiders? 14.89% of Eton Pharmaceuticals stock is owned by insiders. Learn more on ETON's insider holdings. Which Eton Pharmaceuticals insiders have been buying company stock? The following insider purchased ETON shares in the last 24 months: Opaleye Management Inc. ($462,673.60). How much insider buying is happening at Eton Pharmaceuticals? Insiders have purchased a total of 85,600 ETON shares in the last 24 months for a total of $462,673.60 bought. Which Eton Pharmaceuticals insiders have been selling company stock? The following insider sold ETON shares in the last 24 months: David Krempa ($504,317.63). How much insider selling is happening at Eton Pharmaceuticals? Insiders have sold a total of 34,000 Eton Pharmaceuticals shares in the last 24 months for a total of $504,317.63 sold. Eton Pharmaceuticals Key ExecutivesMr. Sean E. Brynjelsen (Age 52)President, CEO & Director Compensation: $939.42kMr. James R. Gruber CPA (Age 52)CFO, Treasurer & Secretary Compensation: $554.44kMr. David C. Krempa (Age 35)Chief Business Officer Compensation: $547.86k3 recent tradesMs. Ingrid HoosSenior Vice President of Regulatory AffairsMr. Kevin GuthrieExecutive VP of Commercial Operations More Insider Trading Tools from MarketBeat Related Companies ADPT Insider Trades SDGR Insider Trades JANX Insider Trades ABCL Insider Trades EWTX Insider Trades ANIP Insider Trades NTLA Insider Trades ETNB Insider Trades VERA Insider Trades BHVN Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:ETON) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
